ZLD1039
CAS No. 1826865-46-6
ZLD1039( —— )
Catalog No. M34479 CAS No. 1826865-46-6
ZLD1039 is a potent, orally bioavailable EZH2 (Enhancer of Zeste Homolog 2) inhibitor with high selectivity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 64 | In Stock |
|
| 10MG | 101 | In Stock |
|
| 25MG | 226 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameZLD1039
-
NoteResearch use only, not for human use.
-
Brief DescriptionZLD1039 is a potent, orally bioavailable EZH2 (Enhancer of Zeste Homolog 2) inhibitor with high selectivity.
-
DescriptionZLD1039 is a potent, highly selective, and orally bioavailable EZH2 inhibitor. ZLD1039 shows potent and concentration-dependent inhibition of PRC2 enzymatic activity against EZH2 wild-type as well as Y641F, and A677G mutant enzymes with IC50 values of 5.6, 15, and 4.0 nM, respectively. ZLD1039 inhibits breast tumor growth and metastasis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorHistone Methyltransferase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1826865-46-6
-
Formula Weight612.8
-
Molecular FormulaC36H48N6O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 9.09 mg/mL (14.83 mM; ultrasonic and adjust pH to 3 with 1M HCl
-
SMILESCCN(C1CCOCC1)c1cc(cc(C(=O)NCc2c3CCCCc3c(C)[nH]c2=O)c1C)-c1ccc(nc1)N1CCN(C)CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Anisole
Anisole is a nature flavouring agent that is a precursor to perfumes insect pheromones and pharmaceuticals.
-
Valeroyl Salicylate
Valeroyl Salicylate is a non-steroidal anti-inflammatory agent and can lead to extension of lifespan, delays age-dependent decline of locomotor activity, and increases stress resistance.
-
Eugeniin
Tellimagrandin II (Eugeniin), with oral activity, is the first intermediate of the ellagitannin series derived from 4C1-glucose. It inhibits the resistance of Staphylococcus aureus by disrupting the integrity of the cell wall, leading to the loss of cytoplasmic contents. Additionally, Tellimagrandin II exhibits anti-inflammatory effects and inhibits acetylcholinesterase (AChE) activity, improving memory impairment. Tellimagrandin II holds potential for research in the fields of antibacterial, anti-inflammatory, and neurodegenerative diseases.
Cart
sales@molnova.com